Cargando…

Reply to “PEG skin testing for COVID-19 allergy”

Detalles Bibliográficos
Autores principales:	Banerji, Aleena, Phillips, Elizabeth, Saff, Rebecca, Wickner, Paige G., Robinson, Lacey B., Wolfson, Anna R., Williams, Paul, Khan, David A., Blumenthal, Kimberly G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Correspondence and Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024681/ https://www.ncbi.nlm.nih.gov/pubmed/33838846 http://dx.doi.org/10.1016/j.jaip.2021.02.015

Ejemplares similares

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

PEG skin testing for COVID-19 vaccine allergy
por: Stone, Bryan D.
Publicado: (2021)

Reply to “Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines”
por: Picard, Matthieu, et al.
Publicado: (2022)

COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach
por: Banerji, Aleena, et al.
Publicado: (2021)

mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
por: Banerji, Aleena, et al.
Publicado: (2021)

First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
por: Wolfson, Anna R., et al.
Publicado: (2021)

Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines
por: Mathes, Sonja, et al.
Publicado: (2022)

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
por: Blumenthal, Kimberly G., et al.
Publicado: (2021)

Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination
por: Li, Lily, et al.
Publicado: (2021)

Reply to D. O'Reilly et al
por: Patel, Amol, et al.
Publicado: (2021)

Reply to “Mortality-related immune features and COVID-19”
por: Cai, Li, et al.
Publicado: (2021)

Reply
por: Villa, E, et al.
Publicado: (2001)

In reply:
por: Starčević Čizmarević, Nada, et al.
Publicado: (2021)

Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter"
por: Strauss, Ronald, et al.
Publicado: (2022)

Reply to “Does asthma affect outcomes of patients with COVID-19 infections?”
por: Mahdavinia, Mahboobeh, et al.
Publicado: (2021)

Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”
por: Marcus-Mandelblit, Nufar, et al.
Publicado: (2023)

The Authors’ Reply
por: Mallik, Sarmila, et al.
Publicado: (2012)

The authors’ reply
por: El-Kannishy, Ghada M.
Publicado: (2018)

The authors’ reply
por: Kim, Hyo Shik, et al.
Publicado: (2017)

Authors’ reply
por: Myrtennäs, Kerstin, et al.
Publicado: (2017)

The author’s reply
por: Park, Chun Soo
Publicado: (2022)

The author’s reply
por: Park, Hyung Joo
Publicado: (2022)

Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”
por: Bansal, Priya, et al.
Publicado: (2021)

Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
por: Ballow, Mark, et al.
Publicado: (2021)

Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era”
por: Lang, Claudia Cécile Valérie, et al.
Publicado: (2021)

Reply to “Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?”
por: Ferastraoaru, Denisa, et al.
Publicado: (2021)

Reply to “Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma”
por: Feng, Lan, et al.
Publicado: (2022)

Rapid progress in our understanding of COVID-19 vaccine allergy: A cause for optimism, not hesitancy
por: Banerji, Aleena, et al.
Publicado: (2022)

Reply to “Risk of severe COVID-19 infection in International Space Station astronauts despite routine pre-mission measures”
por: Crucian, Brian E., et al.
Publicado: (2021)

AUTHORS REPLY
por: JOOB, Beuy, et al.
Publicado: (2014)

Reply to the Comment of G. Feulner
por: Weber, Werner
Publicado: (2011)

In Reply to: Fine Needle Aspiration
por: Ehsanbakhsh, Ali-Reza, et al.
Publicado: (2014)

Reply to the Comment by Littlechild and Isupov
por: Willetts, Andrew, et al.
Publicado: (2017)

Reply: “Comment on: The Vitamin D–Folate Hypothesis as an Evolutionary Model for Skin Pigmentation: An Update and Integration of Current Ideas, Nutrients 2018, 10, 554”
por: Jones, Patrice, et al.
Publicado: (2018)

Reply to “The Carotid Sinus as a Viscometer”
por: Lee, Ui Yun, et al.
Publicado: (2020)

Reply to ‘Management of noncompaction requires optimisation’
por: Gurunathan, Sothinathan, et al.
Publicado: (2019)

Reply to correspondence ‘Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a “stochastic” process’ by Gonzalez et al., Retrovirology 2017
por: Oberle, Corinna S., et al.
Publicado: (2017)

The Slopes Remain the Same: Reply to Wolfe (2016)
por: Kristjánsson, Árni
Publicado: (2016)

The Paradox of Ingestion of Dietary Cholesterol in “Vegans”—Reply
por: Clarys, Peter, et al.
Publicado: (2017)

Reply to “Dyslexia: Still Not a Neurodevelopmental Disorder”
por: Fraga González, Gorka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_74mlkqkke6dll6vrpitlbqunrs